Couple User Preferences in Dual Purpose Prevention Products (CUPID)

Dual Purpose Prevention (DPP) Product Preferences Among Couples

MTN-045 is a cross-sectional study that will utilize questionnaires, including Discrete-Choice Experiments (DCE) and joint decision tasks, to assess couples' preferences related to dual purpose prevention (DPP) products that could be used to prevent unintended pregnancies and HIV infection. Post-survey explanatory in-depth interviews (IDIs) will be conducted with a subset of participants to explore DPP product-related decisions..

Study Overview

• Status: Completed
• Conditions: HIV Prevention; Contraception Behavior

Detailed Description

MTN-045 is a cross-sectional study that will utilize questionnaires, including DCEs and joint decision tasks, and IDIs to assess heterosexual couples' preferences related to DPP products that could be used to prevent unintended pregnancies and HIV infection. One main goal of the study is to determine heterosexual couples' preferences for a DPP product to inform product delivery and future product design to maximize uptake and willingness to use among sub-Saharan African heterosexual couples. Another main goal of the study is to assess the level of influence of the male partner on a woman's preferences for a DPP product and on her decision-making process regarding product preferences and use.

The MTN-045 study population will consist of approximately 400 heterosexual sub-Saharan African couples of reproductive age who have been in a relationship for ≥ 3 months and are interested in contraception and/or HIV prevention. Women who are currently using contraceptives as well as those not using contraceptives will be eligible. Couples who are living together as well as those not living together will be eligible. All participants will complete survey questionnaires, first separately from their partner, then followed by a joint couples' decision task. Up to 80 participants, i.e., one or both partners from a subset of up to 40 couples, will be selected to complete an IDI.

• Study Type: Observational
• Enrollment (Actual): 400

Contacts and Locations

Study Locations

• Uganda
  • Kampala, Uganda
    • Makerere University - Johns Hopkins University (MU-JHU) Research
• Zimbabwe
  • Harare, Zimbabwe
    • Zengeza Clinical Research Site

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The MTN-045 study population will consist of approximately 400 heterosexual sub-Saharan African couples of reproductive age who have been in a relationship for ≥ 3 months and are interested in contraception and/or HIV prevention. Women who are currently using contraceptives as well as those not using contraceptives will be eligible. Couples who are living together as well as those not living together will be eligible.

Description

Inclusion Criteria:

Each member of the couple must meet all of the following criteria to be eligible for inclusion in the study, and both members of the couple must be willing and eligible for the couple to enroll:

1. Able and willing to provide written informed consent in one of the study languages.
2. Able and willing to complete the required study procedures.
3. Currently in a heterosexual relationship (living together or not) for at least 3 months (by self-report) with the other member of the couple.

4. At time of Enrollment, expressed interest in contraception and/or HIV prevention (by self-report).

   For female partner:

5. Between the ages of 18 to 40 years (inclusive) at Enrollment, verified per site standard operating procedures (SOPs).

6. HIV negative (by self-report).

   For male partner:

7. Aged 18 years or older at Enrollment, verified per site SOPs.

Exclusion Criteria:

Potential participants who meet the following criteria will be excluded from the study along with their partner:

1. Has any significant medical condition or other condition that, in the opinion of the Investigator of Record (IoR)/designee, would preclude informed consent, make study participation unsafe (including risk for IPV as a result of study participation), complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Study Plan

How is the study designed?

Design Details

• Observational Models: Ecologic or Community
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Attributes of a DPP product that influence preferences among heterosexual couples	Survey questionnaires	12-15 months during Q2 2019/Q4 2020
Differences in DPP product attribute preferences when comparing individual to couples' choices (e.g., woman's individual preferences vs. preferences indicated through the joint couples decision task)	Discrete-Choice Experiments (DCE)	12-15 months during Q2 2019/Q4 2020

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Salient relationship-based and decision-making factors that influence DPP product interest and preferences	Survey questionnaires	12-15 months during Q2 2019/Q4 2020
Differences in attributes salient to preferences by sociodemographic factors such as age and parity that may reflect lifecourse stage	Survey questionnaires	12-15 months during Q2 2019/Q4 2020

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Salient relationship characteristics, norms and communication factors that influenced participants' decision-making process	Survey questionnaires	12-15 months during Q2 2019/Q4 2020
Differences in product preferences, when comparing individual to couples' choices, that characterize the male partner's role in females' preferences	Discrete-Choice Experiments (DCE)	12-15 months during Q2 2019/Q4 2020
Likelihood of using each DPP product, overall and by subgroup, as estimated through analysis of DCE data	Discrete-Choice Experiments (DCE)	12-15 months during Q2 2019/Q4 2020

Collaborators and Investigators

• Sponsor: Microbicide Trials Network
• Collaborators: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH)
• Investigators: Study Chair: Alexandra Minnis, PhD, Research Triangle Institute (RTI) International

Publications and helpful links

General Publications

• Minnis AM, Etima J, Musara P, Browne EN, Mutero P, Kemigisha D, Mgodi NM, Nakabiito C, Shapley-Quinn MK, Stoner MCD, Hartmann M, Macagna N, Piper J, van der Straten A. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS Behav. 2022 Dec;26(12):3848-3861. doi: 10.1007/s10461-022-03713-6.

Study record dates

Study Major Dates

• Study Start (Actual): January 21, 2020
• Primary Completion (Actual): November 5, 2020
• Study Completion (Actual): November 5, 2020

Study Registration Dates

• First Submitted: March 14, 2019
• First Submitted That Met QC Criteria: July 15, 2019
• First Posted (Actual): July 18, 2019

Study Record Updates

• Last Update Posted (Actual): October 13, 2022
• Last Update Submitted That Met QC Criteria: October 11, 2022
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: MTN-045; UM1AI068633 (U.S. NIH Grant/Contract); UM1AI068615 (U.S. NIH Grant/Contract); UM1AI106707 (U.S. NIH Grant/Contract); 38598 (Other Identifier: DAIDS)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No